The aim of this study was to evaluate the therapeutic efficacy and the immunological response in irritant contact dermatitis (ICD) and contact hypersensitivity (CHS) mouse models of the antagonistic CCL5 mutants. Here, CCL5 is linked to impulse control disorder.